BSCL2
Seipin
Also known as: BSCL2_HUMAN, GNG3LG, seipin, SPG17
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96G97
- Gene
- BSCL2
- Ensembl
- ENSG00000168000
- Chromosome
- 11
- Canonical length
- 398 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters
OverviewNCBI Gene
This gene encodes the multi-pass transmembrane protein seipin. This protein localizes to the endoplasmic reticulum and may be important for lipid droplet morphology. Mutations in this gene have been associated with congenital generalized lipodystrophy type 2 or Berardinelli-Seip syndrome, a rare autosomal recessive disease characterized by a near absence of adipose tissue and severe insulin resistance. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. Naturally occurring read-through transcription occurs between this locus and the neighboring locus HNRNPUL2 (heterogeneous nuclear ribonucleoprotein U-like 2).[provided by RefSeq, Jul 2024]
Canonical amino-acid sequenceUniProt
398 residues, UniProt reviewed canonical sequence.
>Q96G97|BSCL2
1 MVNDPPVPAL LWAQEVGQVL AGRARRLLLQ FGVLFCTILL LLWVSVFLYG SFYYSYMPTV
61 SHLSPVHFYY RTDCDSSTTS LCSFPVANVS LTKGGRDRVL MYGQPYRVTL ELELPESPVN
121 QDLGMFLVTI SCYTRGGRII STSSRSVMLH YRSDLLQMLD TLVFSSLLLF GFAEQKQLLE
181 VELYADYREN SYVPTTGAII EIHSKRIQLY GAYLRIHAHF TGLRYLLYNF PMTCAFIGVA
241 SNFTFLSVIV LFSYMQWVWG GIWPRHRFSL QVNIRKRDNS RKEVQRRISA HQPGPEGQEE
301 STPQSDVTED GESPEDPSGT EGQLSEEEKP DQQPLSGEEE LEPEASDGSG SWEDAALLTE
361 ANLPAPAPAS ASAPVLETLG SSEPAGGALR QRPTCSSSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BSCL2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 2
- Mean surface accessibility (rSASA)
- 0.49
- Highest tissue expression
- 275 nTPM
Expression across tissuesHPA
Tissue
- hypothalamus: 275 nTPM
- cerebral cortex: 228 nTPM
- basal ganglia: 227 nTPM
- pituitary gland: 219 nTPM
- testis: 169 nTPM
- choroid plexus: 157 nTPM
Single-cell type
- late spermatids: 14 nCPM
- late primary spermatocytes: 7 nCPM
- oocytes: 4.6 nCPM
- early primary spermatocytes: 4.5 nCPM
- epididymal principal cells: 4.3 nCPM
- differentiating spermatogonia: 3.6 nCPM
Immune cell
- classical monocyte: 56 nTPM
- plasmacytoid DC: 53 nTPM
- intermediate monocyte: 44 nTPM
- total PBMC: 41 nTPM
- myeloid DC: 40 nTPM
- NK-cell: 40 nTPM
Brain region
- hypothalamus: 597 nTPM
- pons: 375 nTPM
- midbrain: 248 nTPM
- cerebral cortex: 242 nTPM
- medulla oblongata: 239 nTPM
- basal ganglia: 237 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BSCL2.
Disease | AllUniProt
Conditions BSCL2 is implicated in, by any mechanism.
- Lipodystrophy, congenital generalized, 2 (CGL2) MIM:269700
- Spastic paraplegia 17, autosomal dominant (SPG17) MIM:270685
- Neuronopathy, distal hereditary motor, autosomal dominant 13 (HMND13) MIM:619112
- Encephalopathy, progressive, with or without lipodystrophy (PELD) MIM:615924
Disease | GeneticClinVar
56 pathogenic / likely-pathogenic of 660 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital generalized lipodystrophy type 2
- Charcot-Marie-Tooth disease type 2
- Severe neurodegenerative syndrome with lipodystrophy
- Berardinelli-Seip congenital lipodystrophy
- Hereditary spastic paraplegia 17
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.01
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.26
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- fat cell differentiation
- lipid catabolic process
- lipid droplet formation
- lipid droplet organization
- lipid storage
- negative regulation of lipid catabolic process
- positive regulation of cold-induced thermogenesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Seipin
- Putative adipose-regulatory protein (Seipin)
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BSCL2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BSCL2 as an antibody target. Whether an autoantibody or antibody against BSCL2 could matter depends on whether native BSCL2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BSCL2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BSCL2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...